Opportunity Information: Apply for RFA DA 23 046

The National Institutes of Health (NIH) issued this HEAL Initiative funding opportunity (RFA-DA-23-046) to support the creation of multi-disciplinary RM1 Research Centers focused on making opioid use disorder (OUD) treatment systems more trustworthy and dependable from a patient perspective. The core idea is to fund research centers that do more than study OUD treatment in isolation; they must be built around real-world partnerships with organizations that shape how care is paid for, evaluated, and delivered. These partnerships can include payors and health plans, state-level agencies that oversee substance use services (such as single state agencies or opioid treatment authorities), professional organizations, and other relevant entities that influence provider selection and care improvement.

A defining requirement is that the non-research partner brings a quality measurement and management strategy or system that is either already deployed or actively in development. This could be a framework, set of metrics, performance dashboard, credentialing approach, network inclusion method, or other quality management infrastructure that affects which clinicians or programs are considered "high quality" and how treatment delivery is monitored and improved. The research proposed under the RM1 is expected to substantially advance this quality system through rigorous evaluation and refinement, with the goal of making quality assessment meaningful and actionable for OUD treatment rather than purely administrative.

The activities supported under the award are not limited to technical validation of measures. The FOA emphasizes implementation-relevant outcomes: the quality measurement and management system should be acceptable to patients, clinicians, and providers; it should be feasible to run in routine practice settings; and it should have a clear pathway to scalability and long-term sustainability. Another central theme is equity, meaning the system should not inadvertently disadvantage certain populations, communities, or types of providers, and it should help ensure fair access to high-quality OUD care. In practice, applicants are expected to consider how quality measurement influences provider selection, referral patterns, network participation, and treatment improvement in ways that could either reduce or worsen disparities.

The mechanism is an RM1 Research Center award, and clinical trials are optional under this announcement (projects may include clinical trials, but they are not required). The opportunity is categorized as a discretionary grant in the health and education activity areas and is associated with CFDA numbers 93.213, 93.273, and 93.279. The award ceiling listed is $1,500,000, and the original closing date for applications was February 2, 2023.

Eligibility is broad and includes many types of U.S.-based applicants: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (both with and without 501(c)(3) status); for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly notes additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

Foreign eligibility is limited. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as applicants. However, foreign components are allowed when they meet the NIH definition in the NIH Grants Policy Statement, meaning a U.S. applicant can include certain foreign project elements if they are justified and structured as an allowable foreign component rather than as a foreign applicant organization.

Overall, this FOA is aimed at building research centers that can strengthen the real-world infrastructure patients rely on when seeking OUD care: how "quality" is defined, measured, used to choose providers, and translated into continuous improvement, with strong attention to adoption in practice, durability over time, and equitable impact.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.273, 93.279.
  • This funding opportunity was created on 2022-07-06.
  • Applicants must submit their applications by 2023-02-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 23 046

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Small Business Innovation Research and Small Business Technology Transfer Programs Phase I

Previous opportunity: Notice of Funding Opportunity for Grants to Support Programs that Promote Rule of Law in Poland

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 23 046

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 23 046) also looked into and applied for these:

Funding Opportunity
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) Apply for RFA DA 23 045

Funding Number: RFA DA 23 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) Apply for RFA NS 23 014

Funding Number: RFA NS 23 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) Apply for PAR 22 203

Funding Number: PAR 22 203
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,200,000
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) Apply for RFA DA 23 051

Funding Number: RFA DA 23 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) Apply for RFA AT 23 001

Funding Number: RFA AT 23 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) Apply for RFA AT 23 002

Funding Number: RFA AT 23 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) Apply for PAS 22 207

Funding Number: PAS 22 207
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Apply for PAR 22 216

Funding Number: PAR 22 216
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) Apply for PAS 22 206

Funding Number: PAS 22 206
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) Apply for RFA OD 22 015

Funding Number: RFA OD 22 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 038

Funding Number: RFA CA 22 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Apply for RFA CA 22 039

Funding Number: RFA CA 22 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) Apply for RFA CA 22 040

Funding Number: RFA CA 22 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed) Apply for RFA MH 22 191

Funding Number: RFA MH 22 191
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required) Apply for RFA MH 22 190

Funding Number: RFA MH 22 190
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 22 218

Funding Number: PAR 22 218
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed) Apply for PAR 23 023

Funding Number: PAR 23 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required) Apply for RFA DA 23 048

Funding Number: RFA DA 23 048
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 22 219

Funding Number: PAR 22 219
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
NCI Outstanding Investigator Award (R35 Clinical Trial Optional) Apply for RFA CA 22 045

Funding Number: RFA CA 22 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 046", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: